_________
false
כן-פייט ביופרמה בע"מ
2
381
CAN-FITE BIOPHARMA LTD
Corporation no:
512022153
4330
Israel Securities Authority
Tel Aviv Stock Exchange
C003
(
Public
)
Reported via MAGNA:
25/08/2022
www.isa.gov.il
www.tase.co.il
Reference:
2022-02-108250
Time of broadcast:
11:53
11:53
Other Report or Announcement
Regulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
Financial results for the six months ended June 30, 2022 and updates on its drug development programs and an unaudited interim condensed consolidated financial statements as of June 30, 2022.
ea164764-6k_canfiteEDGAR6_Bannerless_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
-1
Date of revision of form structure:
02/08/2022
Address:
Bareket
10
,
Petach-Tikva
47190
,
Tel:
03-9241114
,
03-9213501
Fax:
03-9249378
E-mail address:
motti@canfite.co.il
Company site:
www.canfite.com
Previous names of reporting entity:
Name of the Signatory:
FISHMAN PNINA
Position of Signatory in the reporting corporation:
Director, CFO
Name of Employer Company:
Address:
BAR-ON
2
,
HERZLIA
4658084
Telephone:
03-9241114
Facsimile:
03-9249378
E-mail:
pnina@canfite.co.il
2